Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Απλή σελίδα τεκμηρίου
dc.contributor.authorVan Cutsem, E.en
dc.contributor.authorDicato, M.en
dc.contributor.authorArber, N.en
dc.contributor.authorBerlin, J.en
dc.contributor.authorCervantes, A.en
dc.contributor.authorCiardiello, F.en
dc.contributor.authorDe Gramont, A.en
dc.contributor.authorDiaz-Rubio, E.en
dc.contributor.authorDucreux, M.en
dc.contributor.authorGeva, R.en
dc.contributor.authorGlimelius, B.en
dc.contributor.authorGlynne Jones, R.en
dc.contributor.authorGrothey, A.en
dc.contributor.authorGruenberger, T.en
dc.contributor.authorHaller, D.en
dc.contributor.authorHaustermans, K.en
dc.contributor.authorLabianca, R.en
dc.contributor.authorLenz, H. J.en
dc.contributor.authorMinsky, B.en
dc.contributor.authorNordlinger, B.en
dc.contributor.authorOhtsu, A.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorRougier, P.en
dc.contributor.authorSchmiegel, W.en
dc.contributor.authorVan de Velde, C.en
dc.contributor.authorSchmoll, H. J.en
dc.contributor.authorSobrero, A.en
dc.contributor.authorTabernero, J.en
dc.date.accessioned2015-11-24T19:04:02Z
dc.date.available2015-11-24T19:04:02Z
dc.identifier.issn1569-8041-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19956
dc.rightsDefault Licence-
dc.subjectAntineoplastic Agents/adverse effectsen
dc.subjectBiological Markers/metabolismen
dc.subjectCarcinoembryonic Antigen/analysisen
dc.subjectColorectal Neoplasms/*drug therapy/genetics/pathologyen
dc.subjectHumansen
dc.subjectMicrosatellite Instabilityen
dc.subjectMutationen
dc.subjectNeoplasm Metastasisen
dc.subjectPrognosisen
dc.subjectProto-Oncogene Proteins/geneticsen
dc.subjectProto-Oncogene Proteins B-raf/geneticsen
dc.subjectReceptor, Epidermal Growth Factor/antagonists & inhibitorsen
dc.subjectSpainen
dc.subjectras Proteins/geneticsen
dc.titleMolecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009en
heal.abstractThe article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1093/annonc/mdq273-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20534623-
heal.identifier.secondaryhttp://annonc.oxfordjournals.org/content/21/suppl_6/vi1.full.pdf-
heal.journalNameAnn Oncolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ